Clemmensen P - Search Results

1

Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary percutaneous coronary intervention: pooled patient-level analysis from the HORIZONS-AMI and EUROMAX trials.

Stone GW, Mehran R, Goldstein P, Witzenbichler B, Van't Hof A, Guagliumi G, Hamm CW, Généreux P, Clemmensen P, Pocock SJ, Gersh BJ, Bernstein D, Deliargyris EN, Steg PG. Stone GW, et al. Among authors: clemmensen p. J Am Coll Cardiol. 2015 Jan 6;65(1):27-38. doi: 10.1016/j.jacc.2014.10.029. J Am Coll Cardiol. 2015. PMID: 25572507 Free article.

2

Effect of intravenous streptokinase on the relation between initial ST-predicted size and final QRS-estimated size of acute myocardial infarcts.

Clemmensen P, Grande P, Saunamäki K, Pedersen F, Svendsen JH, Wagner NB, Granborg J, Madsen JK, Haedersdal C, Wagner GS. Clemmensen P, et al. J Am Coll Cardiol. 1990 Nov;16(5):1252-7. doi: 10.1016/0735-1097(90)90562-4. J Am Coll Cardiol. 1990. PMID: 2229775 Free article. Clinical Trial.

3

Serial prognostic capabilities of electrocardiographic indices of infarcted and hibernating myocardium in predicting short- and long-term outcome following coronary artery bypass surgery.

Holmvang L, Lyck F, Clemmensen P, Behar V, Maynard C, Grande P, Wagner GS. Holmvang L, et al. Among authors: clemmensen p. Cardiology. 1997 Jul-Aug;88(4):333-9. doi: 10.1159/000177356. Cardiology. 1997. PMID: 9197427

4

Continuous monitoring of global left ventricular ejection fraction during percutaneous transluminal coronary angioplasty.

Lindhardt TB, Kelbaek H, Madsen JK, Saunamäki K, Clemmensen P, Hesse B, Gadsbøll N. Lindhardt TB, et al. Among authors: clemmensen p. Am J Cardiol. 1998 Apr 1;81(7):853-9. doi: 10.1016/s0002-9149(98)00005-8. Am J Cardiol. 1998. PMID: 9555774

5

Effects of revascularization after first acute myocardial infarction on the evolution of QRS complex changes (the DANAMI trial). DANish Trial in Acute Myocardial Infarction.

Lyck F, Holmvang L, Grande P, Madsen JK, Wagner GS, Clemmensen P. Lyck F, et al. Among authors: clemmensen p. Am J Cardiol. 1999 Feb 15;83(4):488-92. doi: 10.1016/s0002-9149(98)00900-x. Am J Cardiol. 1999. PMID: 10073848

6

Relative contributions of a single-admission 12-lead electrocardiogram and early 24-hour continuous electrocardiographic monitoring for early risk stratification in patients with unstable coronary artery disease.

Holmvang L, Andersen K, Dellborg M, Clemmensen P, Wagner G, Grande P, Abrahamsson P. Holmvang L, et al. Among authors: clemmensen p. Am J Cardiol. 1999 Mar 1;83(5):667-74. doi: 10.1016/s0002-9149(98)00964-3. Am J Cardiol. 1999. PMID: 10080416 Clinical Trial.

7

Quantitative analysis of the admission electrocardiogram identifies patients with unstable coronary artery disease who benefit the most from early invasive treatment.

Holmvang L, Clemmensen P, Lindahl B, Lagerqvist B, Venge P, Wagner G, Wallentin L, Grande P. Holmvang L, et al. Among authors: clemmensen p. J Am Coll Cardiol. 2003 Mar 19;41(6):905-15. doi: 10.1016/s0735-1097(02)02970-4. J Am Coll Cardiol. 2003. PMID: 12651033 Free article. Clinical Trial.

8

Usefulness of quantitative baseline ST-segment elevation for predicting outcomes after primary coronary angioplasty or fibrinolysis (results from the DANAMI-2 trial).

Sejersten M, Ripa RS, Maynard C, Wagner GS, Andersen HR, Grande P, Mortensen LS, Clemmensen P. Sejersten M, et al. Among authors: clemmensen p. Am J Cardiol. 2006 Mar 1;97(5):611-6. doi: 10.1016/j.amjcard.2005.09.099. Epub 2006 Jan 6. Am J Cardiol. 2006. PMID: 16490423

9

Effects of abciximab as adjunctive therapy in primary percutaneous coronary intervention patients (results from the DANAMI-2 trial).

Sejersten M, Maynard C, Clemmensen P; DANAMI-2 Investigators. Sejersten M, et al. Among authors: clemmensen p. Acute Card Care. 2006;8(2):75-82. doi: 10.1080/14628840600648200. Acute Card Care. 2006. PMID: 16885070 Clinical Trial.

10

Pre-discharge exercise test for evaluation of patients with complete or incomplete revascularization following primary percutaneous coronary intervention: a DANAMI-2 sub-study.

Valeur N, Clemmensen P, Grande P, Wachtell K, Saunamaki K. Valeur N, et al. Among authors: clemmensen p. Cardiology. 2008;109(3):163-71. doi: 10.1159/000106677. Epub 2007 Aug 28. Cardiology. 2008. PMID: 17726317 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

330 results

Search Page

Filters